SICHUAN HEBANG BIOTECHNOLOGY CORPORATION LIMITED

Highlights Sichuan Hebang Biotechnology Corporation Limited

Equities

603077

CNE100001JM9

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
2.06 ^CNY	+0.49%		-2.83%	-12.71%

Apr. 19	Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on January 25, 2024.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on January 25, 2024.	Apr. 01	CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.	Jan. 24	CI
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.	Jan. 24	CI
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on December 15, 2023, has closed with 168,811,563 shares, representing 1.93% for CNY 389.79 million.	Jan. 23	CI
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.	Jan. 23	CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.	Jan. 02	CI
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.	Dec. 15	CI
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on October 19, 2023.	Dec. 15	CI
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.	Dec. 14	CI
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on October 19, 2023, has closed with 170,337,200 shares, representing 1.95% for CNY 399.89 million.	Dec. 14	CI
Hebang Biotechnology to Buy 10.5% Stake in Australia-Listed Avenira For AU$2 Million	Dec. 05	MT
Sichuan Salt Industry Corporation and Sichuan Salt Industry Group West Sichuan Co., Ltd. agreed to acquire 49% stake in Sichuan Shuncheng Salt Products Co., Ltd from Sichuan Hebang Biotechnology Corporation Limited for approximately CNY 150 million.	Dec. 01	CI
Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.	23-10-18	CI
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.	23-10-17	CI
Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Suzhou Everbright Photonics to Set Up Investment Management JV	23-06-22	MT
Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Ganglong China Unit to Offload 35% Stake in China Residential Project for 173 Million Yuan	23-04-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sichuan Hebang Biotechnology Corporation Limited

Equities

603077

CNE100001JM9

Highlights

Filters